NRBO · Categories · Form 4
NRBO - SEC Form 4 insider transactions
NeuroBo Pharmaceuticals Inc. (NRBO) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.
Recent Form 4 for NRBO
- CEO & President Kim Hyung Heon covered exercise/tax liability with 2,867 shares, decreasing direct ownership by 4% to 63,799 units (SEC Form 4)4 - MetaVia Inc. (0001638287) (Issuer)
- Large owner Dong-A St Co., Ltd sold $1,526 worth of shares (407 units at $3.75), decreasing direct ownership by 0.01% to 5,347,792 units (SEC Form 4)4 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
- CEO & President Kim Hyung Heon covered exercise/tax liability with 11,467 shares, decreasing direct ownership by 15% to 66,666 units (SEC Form 4)4 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
- Salsbury Michael was granted 5,051 shares, increasing direct ownership by 40% to 17,552 units (SEC Form 4)4 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
- Groves Jason L was granted 5,051 shares, increasing direct ownership by 40% to 17,552 units (SEC Form 4)4 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
- Koven Andrew I was granted 5,051 shares, increasing direct ownership by 40% to 17,552 units (SEC Form 4)4 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
- Glickman Mark A was granted 5,051 shares, increasing direct ownership by 108% to 9,740 units (SEC Form 4)4 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
- Strickland D Gordon was granted 5,051 shares, increasing direct ownership by 40% to 17,552 units (SEC Form 4)4 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
- Tursi James Patrick was granted 5,051 shares, increasing direct ownership by 126% to 9,072 units (SEC Form 4)4 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
- Woodworth Marshall H was granted 33,496 shares (SEC Form 4)4 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
- Tursi James Patrick was granted 32,157 shares (SEC Form 4)4 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
- SEC Form 4: Kim Hyung Heon was granted 625,064 shares4 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
- SEC Form 4 filed by Koven Andrew I4 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
- SEC Form 4 filed by Salsbury Michael4 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
- SEC Form 4 filed by Strickland D Gordon4 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
- SEC Form 4 filed by Groves Jason L4 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
- SEC Form 4 filed by Glickman Mark A4 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
- SEC Form 4 filed by Kim Na Yeon4 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
- SEC Form 4 filed by Kim Na Yeon (Amendment)4/A - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
- SEC Form 4: E&Investment, Inc. disposed of 1,445,267 shares4 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
- SEC Form 4: Kim Na Yeon disposed of 1,445,267 shares4 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
- SEC Form 4 filed by Kim Na Yeon4 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
- SEC Form 4 filed by Groves Jason L4 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
- SEC Form 4 filed by Kim Hyung Heon4 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
- SEC Form 4 filed by Kang Richard4 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
- SEC Form 4 filed by Strickland D Gordon4 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
- SEC Form 4 filed by Salsbury Michael4 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
- SEC Form 4 filed by Koven Andrew I4 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
- SEC Form 4 filed by Strickland D Gordon4 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
- SEC Form 4 filed by Price Ben Gil4 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
- SEC Form 4 filed by Koven Andrew I4 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)